Pfizer Inc., Andover, Massachusetts, USA.
AbbVie, Irvine, California, USA.
AAPS PharmSciTech. 2023 Apr 3;24(4):96. doi: 10.1208/s12249-023-02553-4.
Scale-up and transfer of lyophilization processes remain very challenging tasks considering the technical challenges and the high cost of the process itself. The challenges in scale-up and transfer were discussed in the first part of this paper and include vial breakage during freezing at commercial scale, cake resistance differences between scales, impact of differences in refrigeration capacities, and geometry on the performance of dryers. The second part of this work discusses successful and unsuccessful practices in scale-up and transfer based on the experience of the authors. Regulatory aspects of scale-up and transfer of lyophilization processes were also outlined including a topic on the equivalency of dryers. Based on an analysis of challenges and a summary of best practices, recommendations on scale-up and transfer of lyophilization processes are given including projections on future directions in this area of the freeze drying field. Recommendations on the choice of residual vacuum in the vials were also provided for a wide range of vial capacities.
考虑到技术挑战和工艺本身的高成本,将冻干工艺放大和转移仍然是非常具有挑战性的任务。在本文的第一部分讨论了放大和转移过程中的挑战,包括在商业规模冷冻过程中瓶子破裂、不同规模之间的蛋糕阻力差异、制冷能力差异以及对干燥器性能的影响。本文的第二部分根据作者的经验讨论了放大和转移中的成功和失败实践。还概述了冻干工艺放大和转移的监管方面,包括关于干燥器等效性的主题。基于对挑战的分析和最佳实践的总结,给出了冻干工艺放大和转移的建议,包括对该领域未来发展方向的预测。还针对各种容量的瓶子提供了关于瓶中残余真空选择的建议。